Laboratory Workflow, assay or product performance, medical or economic outcomes
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics.
Since 1963, we have been innovating to drive progress in pathogen detection and identification.
Scope of research can include, but is not restricted to, assessing laboratory workflow, assay or product performance, and important medical or economic outcomes.
We support sponsored studies to add to the body of knowledge about bioMérieux products. We do not support studies to influence individual purchasing decisions.
bioMérieux-Initiated Research (BIR) projects are those which are conceived, designed, implemented and supported entirely by bioMérieux, in collaboration with external partners (clinicians, researchers, universities, other companies, NGOs, etc.).
Investigator-Initiated Research (IIR) projects are those which are conceived, designed, and implemented primarily by an external party, and only partially supported by bioMérieux in a limited capacity in terms of providing any or all of the following: funding, reagents, loan of instruments, training.
Proposals must be submitted in English and are reviewed by a committee of medical and scientific staff who regularly review these proposals. Please take the time to describe the study in adequate detail so that our review committee has a good understanding of the study design, objectives, and workflow. bioMérieux may decide to support studies by providing any or all of the following: scientific expertise, funding, reagents, loan of instruments, training.
In reviewing study proposals, we consider whether the proposed study:
- Is well described and has a scientifically valid study design.
- Is aligned with bioMérieux research goals of evaluating the technical, medical, and/or economic value of bioMérieux products to patients, health care providers, administrators, laboratories, healthcare systems and/or payers.
- Provides incremental value to the current body of knowledge regarding bioMérieux products.
- Complies with regulatory requirements, ethical standards, and bioMérieux’ business standards.
- Is conducted by experienced and qualified investigators.
- Is expected to result in publication in a peer-reviewed journal or other recognized professional forum within two years of initiation.
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.